|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - Gianakakos Anastasios - Portfolio Holdings (Majority Ownership)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
GIANAKAKOS ANASTASIOS: Insider Trading and Stock Options
Common stock purchase or sale:
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-11-02 Sale |
2009-11-04 2:15 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $8.06 | $36,268 | 729 (Direct) | View |
| 2009-10-01 Sale |
2009-10-05 5:19 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $10.2 | $45,880 | 729 (Direct) |
View |
| 2009-09-08 Sale |
2009-09-10 12:02 pm |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $10.03 | $45,127 | 729 (Direct) |
View |
| 2009-07-10 Sale |
2009-07-14 5:26 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 25,000 | $10.16 | $254,000 | 729 (Direct) |
View |
| 2009-02-04 Sale | 2009-02-05 3:01 pm |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 15,000 | $12 | $180,037 | 0 (Direct) | View |
| 2008-07-07 Sale | 2008-07-08 1:24 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 600 | $10.03 | $6,020 | 0 (Direct) |
View |
| 2008-07-02 Sale |
2008-07-07 5:10 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 2,200 | $10.1 | $22,217 | 0 (Direct) | View |
| 2008-07-02- -2008-07-03 Sale | 2008-07-07 5:10 pm |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 3,000 | $10.12 | $30,352 | 0 (Direct) | View |
| 2008-07-01 Sale | 2008-07-02 12:39 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 3,900 | $10.33 | $40,282 | 0 (Direct) | View |
| 2008-06-04 Sale | 2008-06-05 2:04 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 3,500 | $12.68 | $44,366 | 0 (Direct) |
View |
| 2008-06-03 Sale | 2008-06-04 1:15 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 2,500 | $11.98 | $29,957 | 0 (Direct) |
View |
| 2008-06-02 Sale | 2008-06-03 5:57 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 4,000 | $12.32 | $49,271 | 0 (Direct) |
View |
| 2008-05-16 Sale |
2008-05-20 1:03 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 5,300 | $11.48 | $60,855 | 0 (Direct) |
View |
| 2008-05-19 Sale |
2008-05-20 1:03 pm |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 1,700 | $10.93 | $18,573 | 0 (Direct) |
View |
| 2008-05-15 Sale |
2008-05-19 7:35 pm |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 600 | $12.09 | $7,254 | 0 (Direct) |
View |
| 2008-05-15 Sale | 2008-05-19 7:34 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 7,400 | $11.91 | $88,108 | 600 (Direct) |
View |
Other transactions:
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Ownership | Filing |
| 2009-11-02 Exercise | 2009-11-04 2:15 pm |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $0.7434 | $3,345 | 5,229 (Direct) | View |
| 2009-10-01 Exercise |
2009-10-05 5:19 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $0.7434 | $3,345 | 5,229 (Direct) |
View |
| 2009-09-08 Exercise |
2009-09-10 12:02 pm |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $0.7434 | $3,345 | 5,229 (Direct) | View |
| 2009-07-10 Exercise | 2009-07-14 5:26 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 25,000 | $0.7434 | $18,585 | 25,729 (Direct) | View |
| 2009-02-04 Exercise | 2009-02-05 3:01 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 15,000 | $0.7434 | $11,151 | 15,000 (Direct) | View |
| 2008-07-07 Exercise | 2008-07-08 1:24 pm |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 600 | $0.7434 | $446 | 600 (Direct) | View |
| 2008-07-02 Exercise |
2008-07-07 5:10 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 2,200 | $0.7434 | $1,635 | 2,200 (Direct) |
View |
| 2008-07-02- -2008-07-03 Exercise |
2008-07-07 5:10 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 3,000 | $0.7434 | $2,230 | 800 (Direct) |
View |
| 2008-07-01 Exercise | 2008-07-02 12:39 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 3,900 | $0.7434 | $2,899 | 3,900 (Direct) |
View |
| 2008-06-04 Exercise | 2008-06-05 2:04 pm |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 3,500 | $0.7434 | $2,602 | 3,500 (Direct) |
View |
| 2008-06-03 Exercise | 2008-06-04 1:15 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 2,500 | $0.7434 | $1,858 | 2,500 (Direct) | View |
| 2008-06-02 Exercise | 2008-06-03 5:57 pm |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 4,000 | $0.7434 | $2,974 | 4,000 (Direct) |
View |
| 2008-05-16 Exercise | 2008-05-20 1:03 pm |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 5,300 | $0.7434 | $3,940 | 5,300 (Direct) |
View |
| 2008-05-19 Exercise |
2008-05-20 1:03 pm |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 1,700 | $0.7434 | $1,264 | 1,700 (Direct) | View |
| 2008-05-15 Exercise | 2008-05-19 7:34 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 8,000 | $0.7434 | $5,947 | 8,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction & Date | Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2009-11-02 Exercise |
2009-11-04 2:15 pm |
N/A 2016-10-16 |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $0.7434 | 53,143 (Direct) |
View |
| 2009-10-01 Exercise | 2009-10-05 5:19 pm |
N/A 2016-10-16 | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $0.7434 | 57,643 (Direct) | View |
| 2009-09-08 Exercise | 2009-09-10 12:02 pm |
N/A 2016-10-16 | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $0.7434 | 62,143 (Direct) | View |
| 2009-07-10 Exercise |
2009-07-14 5:26 pm | N/A 2016-10-16 |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 25,000 | $0.7434 | 66,643 (Direct) | View |
| 2009-02-11 Option Award | 2009-02-13 5:03 pm | N/A 2019-02-10 |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 100,000 | $10.37 | 100,000 (Direct) |
View |
| 2009-02-04 Exercise | 2009-02-05 3:01 pm |
N/A 2016-10-16 |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 15,000 | $0.7434 | 91,643 (Direct) | View |
| 2008-07-07 Exercise |
2008-07-08 1:24 pm | N/A 2016-10-16 |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 600 | $0.7434 | 106,643 (Direct) |
View |
| 2008-07-02 Exercise | 2008-07-07 5:10 pm | N/A 2016-10-16 |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 2,200 | $0.7434 | 108,043 (Direct) | View |
| 2008-07-02 Exercise | 2008-07-07 5:10 pm | N/A 2016-10-16 | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 2,200 | $0.7434 | 108,043 (Direct) | View |
| 2008-07-03 Exercise | 2008-07-07 5:10 pm |
N/A 2016-10-16 | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 800 | $0.7434 | 107,243 (Direct) | View |
| 2008-07-01 Exercise |
2008-07-02 12:39 pm | N/A 2016-10-16 | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 3,900 | $0.7434 | 110,243 (Direct) |
View |
| 2008-06-04 Exercise | 2008-06-05 2:04 pm |
N/A 2016-10-16 |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 3,500 | $0.7434 | 114,143 (Direct) | View |
| 2008-06-03 Exercise | 2008-06-04 1:15 pm | N/A 2016-10-16 |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 2,500 | $0.7434 | 117,643 (Direct) | View |
| 2008-06-02 Exercise |
2008-06-03 5:57 pm | N/A 2016-10-16 | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 4,000 | $0.7434 | 120,143 (Direct) | View |
| 2008-05-16 Exercise | 2008-05-20 1:03 pm |
N/A 2016-10-16 |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 5,300 | $0.7434 | 125,843 (Direct) |
View |
| 2008-05-19 Exercise |
2008-05-20 1:03 pm |
N/A 2016-10-16 | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 1,700 | $0.7434 | 124,143 (Direct) |
View |
| 2008-05-15 Exercise |
2008-05-19 7:34 pm |
N/A 2016-10-16 | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 8,000 | $0.7434 | 131,143 (Direct) |
View |
| 2008-01-22 Option Award |
2008-01-24 6:52 pm |
N/A 2018-01-21 | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, COR & Business Dev) | 40,000 | $13.12 | 40,000 (Direct) |
View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 19:42:20 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |